IMARC Group, a leading market research company, has recently releases report titled “Atherectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global atherectomy devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the atherectomy devices market?
The global atherectomy devices market size reached US$ 930 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,260 Million by 2028, exhibiting a growth rate (CAGR) of 5% during 2023-2028.
What are atherectomy devices?
Atherectomy devices refer to numerous minimally invasive (MI) instruments utilized for peripheral vascular intervention procedures. The devices re-establish blood flow in the arteries through drilling, grinding, sanding, shaving, and vaporizing plaque, calcifying lesions, and excessive cellular materials. Atherectomy devices comprise of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the calcified lesion or plaque. Few most commonly used atherectomy devices are direction, orbital, photo-ablative, rotational, and support atherectomy devices. They are widely adopted across hospitals, surgical centers, and ambulatory care facilities.
Request for a sample copy of this report: https://www.imarcgroup.com/atherectomy-devices-market/requestsample
What are the growth prospects and trends in the atherectomy devices industry?
The rising incidences of peripheral artery disease (PAD), atherosclerosis, diabetes, obesity, etc., along with the increasing geriatric population are primarily driving the need for atherectomy devices. Moreover, the growing preferences towards minimally-invasive atherectomy surgical procedures with reduced pain and faster recovery rate are also propelling the market growth. Additionally, several product innovations, such as drug-coated balloons (DCB) that are used in place of permanent implants with directional atherectomy and anti-restenosis therapy (DAART),will continue to drive the market for atherectomy devices in the coming years.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Directional Atherectomy Devices
- Orbital Atherectomy Devices
- Photo-Ablative Atherectomy Devices
- Rotational Atherectomy Devices
- Support Devices
Breakup by Application:
- Peripheral Vascular
- Cardiovascular
- Neurovascular
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Research Laboratories and Academic Institutes
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- Avinger
- Braun Group
- Biomerics
- Biotronik
- Boston Scientific
- Bard (BD)
- Cardinal Health
- Koninklijke Philips
- Medtronic
- Minnetronix Inc.
- Straub Medical AG (BD)
- Terumo Corporation
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal